198 related articles for article (PubMed ID: 25220236)
1. SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene.
Moon H; Cho S; Loh TJ; Oh HK; Jang HN; Zhou J; Kwon YS; Liao DJ; Jun Y; Eom S; Ghigna C; Biamonti G; Green MR; Zheng X; Shen H
Biochim Biophys Acta; 2014 Nov; 1839(11):1132-40. PubMed ID: 25220236
[TBL] [Abstract][Full Text] [Related]
2. RRM but not the Asp/Glu domain of hnRNP C1/C2 is required for splicing regulation of Ron exon 11 pre-mRNA.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Kim HH; Zheng X; Shen H
BMB Rep; 2019 Nov; 52(11):641-646. PubMed ID: 31401978
[TBL] [Abstract][Full Text] [Related]
3. A 2-nt RNA enhancer on exon 11 promotes exon 11 inclusion of the Ron proto-oncogene.
Moon H; Cho S; Loh TJ; Zhou J; Ghigna C; Biamonti G; Green MR; Zheng X; Shen H
Oncol Rep; 2014 Jan; 31(1):450-5. PubMed ID: 24189591
[TBL] [Abstract][Full Text] [Related]
4. Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities.
Zhang J; Lieu YK; Ali AM; Penson A; Reggio KS; Rabadan R; Raza A; Mukherjee S; Manley JL
Proc Natl Acad Sci U S A; 2015 Aug; 112(34):E4726-34. PubMed ID: 26261309
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel splicing variants from RON proto-oncogene pre-mRNA.
Moon H; Cho S; Yang X; Zhou J; Loh TJ; Zheng X; Shen H
Oncol Rep; 2012 Dec; 28(6):2217-20. PubMed ID: 22993024
[TBL] [Abstract][Full Text] [Related]
6. Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping.
Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
Cells; 2019 Jul; 8(7):. PubMed ID: 31295920
[TBL] [Abstract][Full Text] [Related]
7. Identification of Regulatory-RNAs for Alternative Splicing of Ron Proto-Oncogene.
Moon H; Zheng X; Loh TJ; Jang HN; Liu Y; Jung DW; Williams DR; Shen H
J Cancer; 2015; 6(12):1346-51. PubMed ID: 26640595
[TBL] [Abstract][Full Text] [Related]
8. Decoding a cancer-relevant splicing decision in the RON proto-oncogene using high-throughput mutagenesis.
Braun S; Enculescu M; Setty ST; Cortés-López M; de Almeida BP; Sutandy FXR; Schulz L; Busch A; Seiler M; Ebersberger S; Barbosa-Morais NL; Legewie S; König J; Zarnack K
Nat Commun; 2018 Aug; 9(1):3315. PubMed ID: 30120239
[TBL] [Abstract][Full Text] [Related]
9. Targeting SR proteins improves SMN expression in spinal muscular atrophy cells.
Wee CD; Havens MA; Jodelka FM; Hastings ML
PLoS One; 2014; 9(12):e115205. PubMed ID: 25506695
[TBL] [Abstract][Full Text] [Related]
10. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
[TBL] [Abstract][Full Text] [Related]
11. Exon Definition Facilitates Reliable Control of Alternative Splicing in the RON Proto-Oncogene.
Enculescu M; Braun S; Thonta Setty S; Busch A; Zarnack K; König J; Legewie S
Biophys J; 2020 Apr; 118(8):2027-2041. PubMed ID: 32336349
[TBL] [Abstract][Full Text] [Related]
12. Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives.
Ghigna C; De Toledo M; Bonomi S; Valacca C; Gallo S; Apicella M; Eperon I; Tazi J; Biamonti G
RNA Biol; 2010; 7(4):495-503. PubMed ID: 20864806
[TBL] [Abstract][Full Text] [Related]
13. SRSF2 Regulation of
Comiskey DF; Montes M; Khurshid S; Singh RK; Chandler DS
Mol Cancer Res; 2020 Feb; 18(2):194-203. PubMed ID: 31662450
[No Abstract] [Full Text] [Related]
14. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
Mayeda A; Helfman DM; Krainer AR
Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
[TBL] [Abstract][Full Text] [Related]
15. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene.
Ghigna C; Giordano S; Shen H; Benvenuto F; Castiglioni F; Comoglio PM; Green MR; Riva S; Biamonti G
Mol Cell; 2005 Dec; 20(6):881-90. PubMed ID: 16364913
[TBL] [Abstract][Full Text] [Related]
16. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
17. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM
Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
[TBL] [Abstract][Full Text] [Related]
19. The HNRNPA2B1-MST1R-Akt axis contributes to epithelial-to-mesenchymal transition in head and neck cancer.
Gupta A; Yadav S; Pt A; Mishra J; Samaiya A; Panday RK; Shukla S
Lab Invest; 2020 Dec; 100(12):1589-1601. PubMed ID: 32669614
[TBL] [Abstract][Full Text] [Related]
20. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CbetaII alternative splicing via phosphorylation of serine/arginine-rich splicing factor SRp40.
Patel NA; Kaneko S; Apostolatos HS; Bae SS; Watson JE; Davidowitz K; Chappell DS; Birnbaum MJ; Cheng JQ; Cooper DR
J Biol Chem; 2005 Apr; 280(14):14302-9. PubMed ID: 15684423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
